Status:
COMPLETED
Effect of Extracorporeal Adsorption of Plasma Neutrophil Extracellular Traps (NET) in Sepsis
Lead Sponsor:
Santersus AG
Conditions:
Sepsis
Sepsis-associated AKI
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This open non-randomized controlled single center study investigates to what extent the removal of circulating Neutrophil Extracellular Traps (NETs) from blood by NucleoCapture device has a positive e...
Detailed Description
The term "sepsis" refers to a clinical syndrome in which a dysregulation of the host's inflammatory reaction to infection leads to a life-threatening of organ dysfunctions. Sepsis and septic shock are...
Eligibility Criteria
Inclusion
- Male or female ≥ 18 and ≤ 75 years of age.
- Meet the clinical criteria of sepsis according to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3))
- Written informed consent
Exclusion
- A terminal state
- Active bleeding or uncontrolled acute massive bleeding
Key Trial Info
Start Date :
January 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04749238
Start Date
January 26 2021
End Date
October 24 2021
Last Update
December 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North-Western Regional Scientific and Clinical Center named after L.G. Sokolov
Saint Petersburg, Russia